30262061|t|Design and synthesis of thymine modified phthalocyanine for Abeta protofibrils photodegradation and Abeta peptide aggregation inhibition.
30262061|a|The formation and accumulation of toxic amyloid beta (Abeta) protofibrils in brain is recognized as the pathological hallmark of alzheimer's disease (AD). Recent research indicated that photodynamic therapy (PDT) has potential to treat AD because reactive oxygen species (ROS) generated by photosensitizers (PS) could degrades Abeta protofibrils. Al3+ and Fe3+ were found at markedly high levels on and around Abeta protofibrils comparing with the normal part of brain. Based on this, a thymine modified Zn phthalocyanine (T-ZnPc), which can specific recognize and has strong affinity with Fe3+ and Al3+, was designed and synthesized. The recognize, affinity, Abeta protofibrils degradation and neuro protection process were monitored via ultraviolet absorption spectrometry (UV), fluorescence emission spectrum, transmission electron microscopy (TEM), flow cytometer and thiazolyl blue tetrazolium bromide (MTT) assay. The results revealed that such affinity effect greatly increases the molar extinction coefficient (from 1.70 x 104 to 4.67 x 104 and 3.30 x 104 after forming Fe-T-ZnPc and Al-T-ZnPc) and activates PDT activity of T-ZnPc to generate abundant ROS to degrade Abeta protofibrils (62% and 81% degradation by Al-T-ZnPc and Fe-T-ZnPc) and prevent its neurotoxicity based on the statistical differences analysis. Besides, T-ZnPc could inhibit new Abeta protofibrils formation and the chelation effect could reduce the free Fe3+ and Al3+ concentration in brain, which could be also helpful for AD treatment.
30262061	24	55	thymine modified phthalocyanine	Chemical	-
30262061	60	65	Abeta	Gene	351
30262061	100	105	Abeta	Gene	351
30262061	178	190	amyloid beta	Gene	351
30262061	192	197	Abeta	Gene	351
30262061	267	286	alzheimer's disease	Disease	MESH:D000544
30262061	288	290	AD	Disease	MESH:D000544
30262061	374	376	AD	Disease	MESH:D000544
30262061	385	408	reactive oxygen species	Chemical	MESH:D017382
30262061	410	413	ROS	Chemical	MESH:D017382
30262061	465	470	Abeta	Gene	351
30262061	485	489	Al3+	Chemical	-
30262061	494	498	Fe3+	Chemical	-
30262061	548	553	Abeta	Gene	351
30262061	625	632	thymine	Chemical	MESH:D013941
30262061	642	659	Zn phthalocyanine	Chemical	MESH:C052159
30262061	661	667	T-ZnPc	Chemical	-
30262061	728	732	Fe3+	Chemical	-
30262061	737	741	Al3+	Chemical	-
30262061	798	803	Abeta	Gene	351
30262061	1010	1044	thiazolyl blue tetrazolium bromide	Chemical	MESH:C022616
30262061	1046	1049	MTT	Chemical	MESH:C070243
30262061	1219	1225	T-ZnPc	Chemical	-
30262061	1233	1239	T-ZnPc	Chemical	-
30262061	1271	1277	T-ZnPc	Chemical	-
30262061	1299	1302	ROS	Chemical	MESH:D017382
30262061	1314	1319	Abeta	Gene	351
30262061	1364	1370	T-ZnPc	Chemical	-
30262061	1378	1384	T-ZnPc	Chemical	-
30262061	1402	1415	neurotoxicity	Disease	MESH:D020258
30262061	1472	1478	T-ZnPc	Chemical	-
30262061	1497	1502	Abeta	Gene	351
30262061	1573	1577	Fe3+	Chemical	-
30262061	1582	1586	Al3+	Chemical	-
30262061	1643	1645	AD	Disease	MESH:D000544
30262061	Association	MESH:D000544	351
30262061	Association	MESH:D017382	351
30262061	Association	MESH:D017382	MESH:D020258

